Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Condition(s):Retinal Degeneration; Inherited Retinal Dystrophy Primarily Involving Sensory RetinaLast Updated:April 19, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Retinal Degeneration; Inherited Retinal Dystrophy Primarily Involving Sensory RetinaLast Updated:April 19, 2019Terminated
Condition(s):Retina; Detachment, RhegmatogenousLast Updated:April 5, 2023Recruiting
Condition(s):Retinitis Pigmentosa; Cone Dystrophy; Usher Syndromes; Retina; DystrophyLast Updated:June 19, 2019Recruiting
Condition(s):Retinal DiseaseLast Updated:October 6, 2020Unknown status
Condition(s):Retinitis PigmentosaLast Updated:May 10, 2019Withdrawn
Condition(s):Stargardts; Retinitis Pigmentosa; Age-related Macular Degeneration; Choroideremia; Geographic AtrophyLast Updated:March 28, 2024Recruiting
Condition(s):Retinal DetachmentLast Updated:March 5, 2024Not yet recruiting
Condition(s):Diabetes; Diabetic Retinopathy; Diabetic Macular Edema; Diabetic Eye ProblemsLast Updated:October 16, 2023Completed
Condition(s):Retinal DystrophiesLast Updated:March 27, 2024Recruiting
Condition(s):Retinopathy of PrematurityLast Updated:September 21, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.